PTEN controls tumor-induced angiogenesis

Shenghua Wen, Javor Stolarov, Michael P. Myers, Jing Dong Su, Michael H. Wigler, Nicholas K. Tonks, Donald L Durden

Research output: Contribution to journalArticle

197 Citations (Scopus)

Abstract

Mutations of the tumor suppressor PTEN, a phosphatase with specificity for 3-phosphorylated inositol phospholipids, accompany progression of brain tumors from benign to the most malignant forms. Tumor progression, particularly in aggressive and malignant tumors, is associated with the induction of angiogenesis, a process termed the angiogenic switch. Therefore, we tested whether PTEN regulates tumor progression by modulating angiogenesis. U87MG glioma cells stably reconstituted with PTEN cDNA were tested for growth in a nude mouse orthotopic brain tumor model. We observed that the reconstitution of wild-type PTEN had no effect on in vitro proliferation but dramatically decreased tumor growth in vivo and prolonged survival in mice implanted intracranially with these tumor cells. PTEN reconstitution diminished phosphorylation of AKT within the PTEN-reconstituted tumor, induced thrombospondin I expression, and suppressed angiogenic activity. These effects were not observed in tumors reconstituted with a lipid phosphatase inactive G129E mutant of PTEN, a result that provides evidence that the lipid phosphatase activity of PTEN regulates the angiogenic response in vivo. These data provide evidence that PTEN regulates tumor-induced angiogenesis and the progression of gliomas to a malignant phenotype via the regulation of phosphoinositide-dependent signals.

Original languageEnglish (US)
Pages (from-to)4622-4627
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume98
Issue number8
DOIs
StatePublished - Apr 10 2001

Fingerprint

Neoplasms
PTEN Phosphohydrolase
Phosphatidylinositols
Brain Neoplasms
Glioma
Genetic Suppression
Thrombospondins
Lipids
Growth
Phosphoric Monoester Hydrolases
Nude Mice
Complementary DNA
Phosphorylation
Phenotype

ASJC Scopus subject areas

  • General

Cite this

PTEN controls tumor-induced angiogenesis. / Wen, Shenghua; Stolarov, Javor; Myers, Michael P.; Su, Jing Dong; Wigler, Michael H.; Tonks, Nicholas K.; Durden, Donald L.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, No. 8, 10.04.2001, p. 4622-4627.

Research output: Contribution to journalArticle

Wen, Shenghua ; Stolarov, Javor ; Myers, Michael P. ; Su, Jing Dong ; Wigler, Michael H. ; Tonks, Nicholas K. ; Durden, Donald L. / PTEN controls tumor-induced angiogenesis. In: Proceedings of the National Academy of Sciences of the United States of America. 2001 ; Vol. 98, No. 8. pp. 4622-4627.
@article{fc8ab6ce5a5c4f7383d6ac4256e83a18,
title = "PTEN controls tumor-induced angiogenesis",
abstract = "Mutations of the tumor suppressor PTEN, a phosphatase with specificity for 3-phosphorylated inositol phospholipids, accompany progression of brain tumors from benign to the most malignant forms. Tumor progression, particularly in aggressive and malignant tumors, is associated with the induction of angiogenesis, a process termed the angiogenic switch. Therefore, we tested whether PTEN regulates tumor progression by modulating angiogenesis. U87MG glioma cells stably reconstituted with PTEN cDNA were tested for growth in a nude mouse orthotopic brain tumor model. We observed that the reconstitution of wild-type PTEN had no effect on in vitro proliferation but dramatically decreased tumor growth in vivo and prolonged survival in mice implanted intracranially with these tumor cells. PTEN reconstitution diminished phosphorylation of AKT within the PTEN-reconstituted tumor, induced thrombospondin I expression, and suppressed angiogenic activity. These effects were not observed in tumors reconstituted with a lipid phosphatase inactive G129E mutant of PTEN, a result that provides evidence that the lipid phosphatase activity of PTEN regulates the angiogenic response in vivo. These data provide evidence that PTEN regulates tumor-induced angiogenesis and the progression of gliomas to a malignant phenotype via the regulation of phosphoinositide-dependent signals.",
author = "Shenghua Wen and Javor Stolarov and Myers, {Michael P.} and Su, {Jing Dong} and Wigler, {Michael H.} and Tonks, {Nicholas K.} and Durden, {Donald L}",
year = "2001",
month = "4",
day = "10",
doi = "10.1073/pnas.081063798",
language = "English (US)",
volume = "98",
pages = "4622--4627",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "8",

}

TY - JOUR

T1 - PTEN controls tumor-induced angiogenesis

AU - Wen, Shenghua

AU - Stolarov, Javor

AU - Myers, Michael P.

AU - Su, Jing Dong

AU - Wigler, Michael H.

AU - Tonks, Nicholas K.

AU - Durden, Donald L

PY - 2001/4/10

Y1 - 2001/4/10

N2 - Mutations of the tumor suppressor PTEN, a phosphatase with specificity for 3-phosphorylated inositol phospholipids, accompany progression of brain tumors from benign to the most malignant forms. Tumor progression, particularly in aggressive and malignant tumors, is associated with the induction of angiogenesis, a process termed the angiogenic switch. Therefore, we tested whether PTEN regulates tumor progression by modulating angiogenesis. U87MG glioma cells stably reconstituted with PTEN cDNA were tested for growth in a nude mouse orthotopic brain tumor model. We observed that the reconstitution of wild-type PTEN had no effect on in vitro proliferation but dramatically decreased tumor growth in vivo and prolonged survival in mice implanted intracranially with these tumor cells. PTEN reconstitution diminished phosphorylation of AKT within the PTEN-reconstituted tumor, induced thrombospondin I expression, and suppressed angiogenic activity. These effects were not observed in tumors reconstituted with a lipid phosphatase inactive G129E mutant of PTEN, a result that provides evidence that the lipid phosphatase activity of PTEN regulates the angiogenic response in vivo. These data provide evidence that PTEN regulates tumor-induced angiogenesis and the progression of gliomas to a malignant phenotype via the regulation of phosphoinositide-dependent signals.

AB - Mutations of the tumor suppressor PTEN, a phosphatase with specificity for 3-phosphorylated inositol phospholipids, accompany progression of brain tumors from benign to the most malignant forms. Tumor progression, particularly in aggressive and malignant tumors, is associated with the induction of angiogenesis, a process termed the angiogenic switch. Therefore, we tested whether PTEN regulates tumor progression by modulating angiogenesis. U87MG glioma cells stably reconstituted with PTEN cDNA were tested for growth in a nude mouse orthotopic brain tumor model. We observed that the reconstitution of wild-type PTEN had no effect on in vitro proliferation but dramatically decreased tumor growth in vivo and prolonged survival in mice implanted intracranially with these tumor cells. PTEN reconstitution diminished phosphorylation of AKT within the PTEN-reconstituted tumor, induced thrombospondin I expression, and suppressed angiogenic activity. These effects were not observed in tumors reconstituted with a lipid phosphatase inactive G129E mutant of PTEN, a result that provides evidence that the lipid phosphatase activity of PTEN regulates the angiogenic response in vivo. These data provide evidence that PTEN regulates tumor-induced angiogenesis and the progression of gliomas to a malignant phenotype via the regulation of phosphoinositide-dependent signals.

UR - http://www.scopus.com/inward/record.url?scp=0035836627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035836627&partnerID=8YFLogxK

U2 - 10.1073/pnas.081063798

DO - 10.1073/pnas.081063798

M3 - Article

VL - 98

SP - 4622

EP - 4627

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 8

ER -